KKR To Support Fuji Soft Privatization Bid: Report
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Aug 07 2024
0mins
Should l Buy KKR?
Source: Benzinga
KKR's Investment in Fuji Soft: KKR plans to support a management buyout of Japanese system developer Fuji Soft, valued at approximately 600 billion yen ($4.09 billion), to enhance its capital efficiency amid shareholder conflicts.
Recent Acquisitions and Stock Performance: KKR shares rose by 1.57% following the announcement of a binding agreement to acquire MercuryGate International Inc. through its joint venture with Körber AG.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy KKR?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on KKR
Wall Street analysts forecast KKR stock price to rise
9 Analyst Rating
9 Buy
0 Hold
0 Sell
Strong Buy
Current: 105.920
Low
145.00
Averages
159.67
High
176.00
Current: 105.920
Low
145.00
Averages
159.67
High
176.00
About KKR
KKR & Co. Inc. is a global investment firm that offers alternative asset management as well as capital markets and insurance solutions. The Company’s segments include Asset Management, Insurance and Strategic Holdings. Asset Management segment offers a range of investment management services to investment funds, vehicles and accounts and provides capital markets services to portfolio companies and third parties. Asset Management segment includes five business lines: Private Equity, Real Assets, Credit and Liquid Strategies, Capital Markets and Principal Activities. Insurance segment is operated by Global Atlantic, which is a United States retirement and life insurance company that provides a suite of protection, legacy and savings products and reinsurance solutions to clients across individual and institutional markets. Global Atlantic offers individuals fixed-rate annuities and others. Strategic Holdings segment represents its participation in its core private equity strategy.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Intel Shares Surge 19% After Earnings Report, Highlighting Turnaround
- Intel Earnings Surge: Intel's stock soared 19% in after-hours trading following its earnings report, now trading around $79, marking a remarkable recovery from a low of $20 just 18 months ago, indicating strong market confidence in its growth prospects.
- Oracle Stock Volatility: Oracle's shares fell 6% today but rebounded in after-hours trading, gaining 20% in April and 34% year-to-date, yet remain nearly 50% below last September's peak, reflecting uncertainty in its performance outlook.
- Private Equity Struggles: Carlyle Group dropped 4.4% on Thursday, down 30% since last September, while Apollo Global and KKR fell 3.3% and 4%, respectively, highlighting a broader weakness in the private equity sector that investors should monitor closely.
- Procter & Gamble and Norfolk Southern Watch: Procter & Gamble's stock has declined 3% over the past three months, 15% off last year's 52-week high, while Norfolk Southern rose 12% and hit a new high, showcasing contrasting performances that warrant investor attention moving forward.
See More
Bain Capital Seeks to Sell 40% Stake in Bridge Data Centres Valued at $5 Billion
- Stake Sale Plan: Bain Capital is looking to sell at least a 40% stake in Bridge Data Centres, which would value the Singapore-based data infrastructure builder at $5 billion, reflecting strong market interest in the data center sector.
- Investment Banks Involved: Bain has hired Citigroup and JPMorgan to manage the sale, which has attracted interest from several private equity and infrastructure funds, indicating a rising demand for data center assets in the market.
- Surging Market Demand: The booming demand for cloud computing, artificial intelligence, and digital services has made data center assets the most sought-after infrastructure investments in Asia, with global M&A deals in this sector projected to reach $98 billion by 2025.
- Historical Context: Founded a decade ago, Bridge Data Centres was merged with Bain Capital and listed on Nasdaq in 2020, later privatized in 2023 for $3.16 billion, underscoring its significant position in the rapidly evolving data center market.
See More
KKR Makes $1.5B Investment in Vertical Bridge for Growth
- Strategic Investment: KKR's $1.5 billion equity investment in Vertical Bridge marks its entry as a new strategic investor, aimed at supporting the company's future growth initiatives.
- Capital Structure Optimization: This investment establishes a fully funded long-term capital structure for Vertical Bridge, ensuring ample financial support for its ongoing development.
- Asset Portfolio Expansion: Vertical Bridge currently owns and operates over 17,000 communications towers, and this investment will further enhance its market position and operational capabilities nationwide.
- Market Outlook: KKR's investment not only secures funding for Vertical Bridge but also reflects confidence in the ongoing growth potential of the communications infrastructure sector, expected to boost the company's competitive edge in the industry.
See More
KKR Invests $1.5 Billion to Support Vertical Bridge's Growth
- Capital Structure Optimization: KKR's $1.5 billion equity investment in Vertical Bridge establishes a fully funded long-term capital structure that supports the company's strategic plan to operate over 17,000 towers nationwide, enhancing its market position.
- Growth Strategy Reinforcement: CEO Ron Bizick stated that this transaction provides the resources necessary for the company to scale its portfolio while maintaining a disciplined, returns-focused capital deployment strategy, ensuring ongoing market competitiveness.
- Rising Infrastructure Demand: KKR's Global Head of Digital Infrastructure, Waldemar Szlezak, highlighted that the densification of 5G and surging data demand are creating a structural need for higher quality wireless infrastructure, which Vertical Bridge is well-positioned to meet with its high-quality tower platform and strong execution track record.
- Long-term Partnership: The participation of existing investors DigitalBridge and La Caisse in this investment underscores their confidence in Vertical Bridge's long-term growth potential, further solidifying the company's leadership position in the communications infrastructure sector.
See More
Thoma Bravo Nears Agreement to Hand Medallia to Lenders
- Equity Loss: Thoma Bravo and its co-investors, who acquired Medallia for $6.4 billion in 2021, are nearing a deal to hand the company over to lenders, which is expected to erase $5.1 billion in equity, highlighting the severity of the investment failure.
- Debt Pressure: Medallia is burdened with $3 billion in debt owed to Apollo, Blackstone, KKR, and Antares Capital, exacerbating its financial difficulties and impacting operational capabilities.
- Market Reaction: Although Thoma Bravo, Blackstone, and KKR declined to comment, the market is rife with uncertainty regarding Medallia's future, which could lead to diminished investor confidence and negatively affect its stock performance.
- Industry Impact: This transaction may prompt a reevaluation of the risks associated with private equity firms in high-leverage acquisitions, particularly in an uncertain economic environment, potentially influencing the structure and execution of similar deals in the future.
See More
HCRx Enters Royalty Monetization Agreement with Oncoceutics
- Royalty Agreement Established: HealthCare Royalty (HCRx) has entered into a royalty monetization agreement with former Oncoceutics shareholders for an undisclosed percentage of royalties on Modeyso® (dordaviprone) commercial sales, indicating HCRx's commitment to new treatment options that could generate significant revenue.
- FDA Approval Context: Modeyso received U.S. FDA accelerated approval in August 2025 for treating patients aged one year and older with diffuse midline glioma harboring an H3 K27M mutation, addressing a critical unmet medical need and potentially increasing HCRx's market share.
- Strong Early Market Performance: Since its launch in August, Modeyso has demonstrated robust early performance, reflecting the urgent demand for treatment among patients with H3 K27M-mutant diffuse midline glioma, which will further enhance HCRx's competitiveness in the biopharmaceutical sector.
- Strategic Investment Implications: HCRx's CEO Clarke Futch noted that the addition of Modeyso will provide significant benefits to patients lacking approved treatment options, showcasing the company's ongoing commitment to biopharmaceutical innovation and potentially driving future business growth.
See More
Intel Shares Surge 19% After Earnings Report, Highlighting Turnaround
- Intel Earnings Surge: Intel's stock soared 19% in after-hours trading following its earnings report, now trading around $79, marking a remarkable recovery from a low of $20 just 18 months ago, indicating strong market confidence in its growth prospects.
- Oracle Stock Volatility: Oracle's shares fell 6% today but rebounded in after-hours trading, gaining 20% in April and 34% year-to-date, yet remain nearly 50% below last September's peak, reflecting uncertainty in its performance outlook.
- Private Equity Struggles: Carlyle Group dropped 4.4% on Thursday, down 30% since last September, while Apollo Global and KKR fell 3.3% and 4%, respectively, highlighting a broader weakness in the private equity sector that investors should monitor closely.
- Procter & Gamble and Norfolk Southern Watch: Procter & Gamble's stock has declined 3% over the past three months, 15% off last year's 52-week high, while Norfolk Southern rose 12% and hit a new high, showcasing contrasting performances that warrant investor attention moving forward.
See More
Bain Capital Seeks to Sell 40% Stake in Bridge Data Centres Valued at $5 Billion
- Stake Sale Plan: Bain Capital is looking to sell at least a 40% stake in Bridge Data Centres, which would value the Singapore-based data infrastructure builder at $5 billion, reflecting strong market interest in the data center sector.
- Investment Banks Involved: Bain has hired Citigroup and JPMorgan to manage the sale, which has attracted interest from several private equity and infrastructure funds, indicating a rising demand for data center assets in the market.
- Surging Market Demand: The booming demand for cloud computing, artificial intelligence, and digital services has made data center assets the most sought-after infrastructure investments in Asia, with global M&A deals in this sector projected to reach $98 billion by 2025.
- Historical Context: Founded a decade ago, Bridge Data Centres was merged with Bain Capital and listed on Nasdaq in 2020, later privatized in 2023 for $3.16 billion, underscoring its significant position in the rapidly evolving data center market.
See More
KKR Makes $1.5B Investment in Vertical Bridge for Growth
- Strategic Investment: KKR's $1.5 billion equity investment in Vertical Bridge marks its entry as a new strategic investor, aimed at supporting the company's future growth initiatives.
- Capital Structure Optimization: This investment establishes a fully funded long-term capital structure for Vertical Bridge, ensuring ample financial support for its ongoing development.
- Asset Portfolio Expansion: Vertical Bridge currently owns and operates over 17,000 communications towers, and this investment will further enhance its market position and operational capabilities nationwide.
- Market Outlook: KKR's investment not only secures funding for Vertical Bridge but also reflects confidence in the ongoing growth potential of the communications infrastructure sector, expected to boost the company's competitive edge in the industry.
See More
KKR Invests $1.5 Billion to Support Vertical Bridge's Growth
- Capital Structure Optimization: KKR's $1.5 billion equity investment in Vertical Bridge establishes a fully funded long-term capital structure that supports the company's strategic plan to operate over 17,000 towers nationwide, enhancing its market position.
- Growth Strategy Reinforcement: CEO Ron Bizick stated that this transaction provides the resources necessary for the company to scale its portfolio while maintaining a disciplined, returns-focused capital deployment strategy, ensuring ongoing market competitiveness.
- Rising Infrastructure Demand: KKR's Global Head of Digital Infrastructure, Waldemar Szlezak, highlighted that the densification of 5G and surging data demand are creating a structural need for higher quality wireless infrastructure, which Vertical Bridge is well-positioned to meet with its high-quality tower platform and strong execution track record.
- Long-term Partnership: The participation of existing investors DigitalBridge and La Caisse in this investment underscores their confidence in Vertical Bridge's long-term growth potential, further solidifying the company's leadership position in the communications infrastructure sector.
See More
Thoma Bravo Nears Agreement to Hand Medallia to Lenders
- Equity Loss: Thoma Bravo and its co-investors, who acquired Medallia for $6.4 billion in 2021, are nearing a deal to hand the company over to lenders, which is expected to erase $5.1 billion in equity, highlighting the severity of the investment failure.
- Debt Pressure: Medallia is burdened with $3 billion in debt owed to Apollo, Blackstone, KKR, and Antares Capital, exacerbating its financial difficulties and impacting operational capabilities.
- Market Reaction: Although Thoma Bravo, Blackstone, and KKR declined to comment, the market is rife with uncertainty regarding Medallia's future, which could lead to diminished investor confidence and negatively affect its stock performance.
- Industry Impact: This transaction may prompt a reevaluation of the risks associated with private equity firms in high-leverage acquisitions, particularly in an uncertain economic environment, potentially influencing the structure and execution of similar deals in the future.
See More
HCRx Enters Royalty Monetization Agreement with Oncoceutics
- Royalty Agreement Established: HealthCare Royalty (HCRx) has entered into a royalty monetization agreement with former Oncoceutics shareholders for an undisclosed percentage of royalties on Modeyso® (dordaviprone) commercial sales, indicating HCRx's commitment to new treatment options that could generate significant revenue.
- FDA Approval Context: Modeyso received U.S. FDA accelerated approval in August 2025 for treating patients aged one year and older with diffuse midline glioma harboring an H3 K27M mutation, addressing a critical unmet medical need and potentially increasing HCRx's market share.
- Strong Early Market Performance: Since its launch in August, Modeyso has demonstrated robust early performance, reflecting the urgent demand for treatment among patients with H3 K27M-mutant diffuse midline glioma, which will further enhance HCRx's competitiveness in the biopharmaceutical sector.
- Strategic Investment Implications: HCRx's CEO Clarke Futch noted that the addition of Modeyso will provide significant benefits to patients lacking approved treatment options, showcasing the company's ongoing commitment to biopharmaceutical innovation and potentially driving future business growth.
See More
